In the last trading session, 1.53 million shares of the Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) were traded, and its beta was 1.82. Most recently the company’s share price was $0.30, and it changed around -$0.01 or -2.48% from the last close, which brings the market valuation of the company to $1.53M. QNRX currently trades at a discount to its 52-week high of $6.18, offering almost -1960.0% off that amount. The share price’s 52-week low was $0.28, which indicates that the current value has risen by an impressive 6.67% since then.

Quoin Pharmaceuticals Ltd ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended QNRX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Quoin Pharmaceuticals Ltd ADR is expected to report earnings per share of -0.43 for the current quarter.

Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information

Instantly QNRX has showed a red trend with a performance of -2.48% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.4700 on recent trading dayincreased the stock’s daily price by 36.17%. The company’s shares are currently down -53.43% year-to-date, but still down -3.69% over the last five days. On the other hand, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) is 4.88% up in the 30-day period.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -194.79%. Quoin Pharmaceuticals Ltd ADR earnings are expected to increase by 78.42% in 2025, but the outlook is positive 82.69% per year for the next five years.

QNRX Dividends

Quoin Pharmaceuticals Ltd ADR’s next quarterly earnings report is expected to be released in April.

The former held 95.0 shares worth $28.0, making up 0.00% of all outstanding shares.